Volume 17, Issue 2 , Pages 192-199, March 2010
Randomized Controlled Study Comparing the Gynecare Morcellex and Rotocut G1 Tissue Morcellators
Abstract
Study Objective
To evaluate the effectiveness of the Gynecare Morcellex tissue morcellator (Ethicon, Inc., Somerville, NJ) in laparoscopic supracervical hysterectomy and myomectomy.
Design
Randomized controlled trial (Evidence I).
Setting
University department of obstetrics and gynecology.
Patients
Seventy-four patients with symptomatic uterine myomas scheduled for laparoscopic supracervical hysterectomy or myomectomy.
Interventions
Laparoscopic supracervical hysterectomy and myomectomy followed by tissue morcellation using the Gynecare Morcellex (experimental group) or the Rotocut G1 morcellator (Karl Storz GmbH & Co. KG, Tuttlingen, Germany) (control group).
Measurements and Main Results
Patient characteristics and surgical data were noted for both groups. No difference was detected between groups in any parameters assessed, whereas a significant difference (p <.05) in handling score was detected in the experimental group compared with the control group.
Conclusion
The Gynecare Morcellex is an effective instrument with excellent safety and handling.
Keywords: Gynecare Morcellex, Laparoscopy, Morcellator, Myomectomy, Rotocut G1, Supracervical hysterectomy
To access this article, please choose from the options below
The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.
PII: S1553-4650(09)01250-3
doi:10.1016/j.jmig.2009.11.009
© 2010 AAGL. Published by Elsevier Inc. All rights reserved.
Volume 17, Issue 2 , Pages 192-199, March 2010
